Philip Roberts
Chief Tech/Sci/R&D Officer chez IMMUNOME, INC.
Profil
Actuellement, Philip Roberts occupe le poste de vice-président principal des opérations techniques chez Mirati Therapeutics, Inc.
Postes actifs de Philip Roberts
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOME, INC. | Chief Tech/Sci/R&D Officer | 04/01/2024 |
Anciens postes connus de Philip Roberts
| Sociétés | Poste | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01/11/2022 |
Formation de Philip Roberts
| Louisiana State University | Graduate Degree |
| Rensselaer Polytechnic Institute | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
